the best overvalued stock to sell now, november 2014

9

Click here to load reader

Upload: conner-management-group-llc

Post on 08-Jul-2015

51 views

Category:

Economy & Finance


0 download

DESCRIPTION

http://gmcstockpicks.com Proprietary algorithms at work. Click here for our free newsletter: http://goo.gl/APYNVJ . Review of the best dividend stock to buy now. Low priced stocks to buy. A great non Disney stock to buy. We do not look at penny stocks. Stock options are a safer bet than penny stocks. Like us on Facebook: https://www.facebook.com/gmconner14 Follow us on Twitter: https://twitter.com/gmcstockpicks Add us to your circles on Google Plus: https://plus.google.com/u/0/+Gmcstockpicks/posts Subscribe to our podcast on iTunes: https://itunes.apple.com/us/podcast/value-momentum-gmc-stock-picks/id737369520?mt=2 We review an overvalued stock in the Healthcare Sector and Drug Manufacture Industry.

TRANSCRIPT

Page 1: The Best Overvalued Stock To Sell Now, November 2014

The Best Over Valued StockTo Sell Now

As of: Monday, November 3rd, 2014

Xxxxxx XxxxxxTicker Symbol: XXXX

Industry: Drug Manufacture

6 Month Downside Potential: -21.9%

Conner Management Group, LLC

Investment Management: www.connermg.com Blog & Newsletter: www.cmgstockpicks.com CMG

Page 2: The Best Overvalued Stock To Sell Now, November 2014

The Best Over Valued StockTo Sell Now

As of: Monday, November 3rd, 2014

Teva PharmaceuticalTicker Symbol: TEVA

Industry: Drug Manufacture

6 Month Downside Potential: -21.9%

Conner Management Group, LLC

Investment Management: www.connermg.com Blog & Newsletter: www.cmgstockpicks.com CMG

Page 3: The Best Overvalued Stock To Sell Now, November 2014

Quick Facts

Company: Teva Pharmaceutical

Headquarters: Petach Tikva, Israel

Year Founded: 1901

# of Employees: 44,945

Ticker Symbol: TEVA

Sector: Healthcare

Industry: Drug Manufacture

Annual Rev. (TTM*): $ 20.5 BN (Billion)

Net Income (TTM): $ 2.8 BN

Cash From Oper.(TTM):$ 4.2 BN

Market Capitalization: $49.4 BN

*TTM – Trailing 12 Months

Business Summary:

Teva Pharmaceutical Industries Limited, together with its subsidiaries, develops, manufactures, sells, and distributes pharmaceutical products worldwide. The company offers generic pharmaceutical products; and basic chemicals, as well as specialized product families. Its products include Copaxone for multiple sclerosis; Azilect for the treatment of Parkinson’s disease; Provigil and Nuvigil to treat excessive sleepiness associated with narcolepsy, obstructive sleep apnea, and shift work disorders; Fentoraand Actiq to treat pain in opioid-tolerant adult patients with cancer; and Amrix for muscle spasm in acute, painful, and musculoskeletal conditions.

Website: www.tevapharm.com

Investment Management: www.connermg.com Blog & Newsletter: www.cmgstockpicks.com CMG

Page 4: The Best Overvalued Stock To Sell Now, November 2014

Products/Services

Investment Management: www.connermg.com Blog & Newsletter: www.cmgstockpicks.com CMG

Page 5: The Best Overvalued Stock To Sell Now, November 2014

Metrics

Courtesy of Yahoo Finance:

Annual Revenue (TTM*): $ 20.5 BN

Net Income (TTM): $ 2.8 BN

Cash From Oper.(TTM): $ 4.2 BN

Oper. Margins: 33.7%(2013), 35.0%(2014)

Trailing P/E Ratio: 11.0

Forward P/E Ratio: 12.0

PEG Ratio: 11.3

Price / Sales: 2.4

Price / Book: 2.0

EV / EBITDA: 9.6

*TTM – Trailing 12 Months

Investment Management: www.connermg.com Blog & Newsletter: www.cmgstockpicks.com

Courtesy of Yahoo Finance:

Recent Closing Price: $57.26

52 Week Low: $36.26

52 Week High: $58.03

20 Day Moving Avg.: $53.17

50 Day Moving Avg.: $52.77

200 Day Moving Avg.: $51.03

Average Volume: 3,868,830

Beta: 0.7

Dividend Yield: 1.9%

Avg. Div. Payout Ratio (3 Yrs.): 24.0%

CMG

Page 6: The Best Overvalued Stock To Sell Now, November 2014

Chart

Courtesy of Yahoo Finance:

Investment Management: www.connermg.com Blog & Newsletter: www.cmgstockpicks.com CMG

TEVA

Page 7: The Best Overvalued Stock To Sell Now, November 2014

Summary

Financial Statement Quality: Excellent

Operating Margin Trend: Flat

Price Pattern Trend: Declining

TiM’s Overall Market Outlook: Neutral

Recent Closing Price: $57.26

CMG 6 Month Price Target: $44.70

6 Month Potential: -21.9%

Investment Management: www.connermg.com Blog & Newsletter: www.cmgstockpicks.com CMG

Page 8: The Best Overvalued Stock To Sell Now, November 2014

About G. Mathis Conner &

Conner Management Group, LLC

• Educational Background of Founder

BS – Mechanical Engineering, RPI

M.Engr. – Mechanical Engineering, Cornell

MBA – Finance, Univ. Of Chicago

• Career Experience

Engineer.

Banker.

Infrastructure Project Investor.

Investment Manager.

• Developer of Proprietary Stock Selection Algorithms

Reviews, analyzes, and ranks over

6,000 stocks weekly.

Uses fundamental, technical, and macro

level measures.

Algorithms estimates future stock prices

with time horizons.

Investment Management: www.connermg.com Blog & Newsletter: www.cmgstockpicks.com

• The primary offering of CMG, LLC is its Managed Account Service – A complement and/or alternative to 401K’s and IRA’s with more benefits. To find out more view the presentation below and visit www.connermg.com .

Click Above To View

CMG

Page 9: The Best Overvalued Stock To Sell Now, November 2014

About G. Mathis Conner &

Conner Management Group, LLC

• Get to know us through our Social Media footprint. We have a presence on the major websites for your convenience – Twitter, Google+ & Facebook. You can be kept abreast of our thinking on stocks investing as well as that of other thought leaders.

Investment Management: www.connermg.com Blog & Newsletter: www.cmgstockpicks.com

• CMG offers two newsletters. One is to keep investors up to date about relevant news and provides in depth analyses on a quality investment opportunity. The other provides the latest top picks from our proprietary algorithms.

CMG Free Newsletter CMG Premium Newsletter

CMG